Trade Summary

3 days ago, Aftab Dana, serving as EVP, Research and Development at EXELIXIS, INC. (EXEL), sold 43,451 shares at $50.35 per share, for a total transaction value of $2,187,757.85. Following this transaction, Aftab Dana now holds 594,741 shares of EXEL.

This sale represents a 6.81% decrease in Aftab Dana's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 26, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 28, 2026 at 6:25 PM ET, 2 days after the trade was made.

EXELIXIS, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.